Second-generation antipsychotic medications and risk of pneumonia in schizophrenia

Chian Jue Kuo, Shu Yu Yang, Ya Tang Liao, Wei J. Chen, Wen Chung Lee, Wen Yi Shau, Yao Tung Chang, Shang Ying Tsai, Chiao Chicy Chen

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

This study assessed the association between second-generation antipsychotic medications and risk of pneumonia requiring hospitalization in patients with schizophrenia because the evidence is limited in the population. We enrolled a nationwide cohort of 33 024 inpatients with schizophrenia ranged in age from 18 to 65 years, who were derived from the National Health Insurance Research Database in Taiwan from 2000 to 2008. Cases (n = 1741) were defined as patients who developed pneumonia after their first psychiatric admissions. Risk set sampling was used to match each case with 4 controls by age, sex, and the year of the first admission based on nested case-control study. Antipsychotic exposure was categorized by type, duration, and daily dose, and the association between exposure and pneumonia was assessed using conditional logistic regression. We found that current use of clozapine (adjusted risk ratio = 3.18, 95% CI: 2.62-3.86, P

Original languageEnglish
Pages (from-to)648-657
Number of pages10
JournalSchizophrenia Bulletin
Volume39
Issue number3
DOIs
Publication statusPublished - May 2013

Fingerprint

Antipsychotic Agents
Schizophrenia
Pneumonia
Clozapine
National Health Programs
Taiwan
Psychiatry
Case-Control Studies
Inpatients
Hospitalization
Logistic Models
Odds Ratio
Databases
Research
Population

Keywords

  • clozapine
  • dose-dependent
  • pneumonia
  • second-generation antipsychotics

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Kuo, C. J., Yang, S. Y., Liao, Y. T., Chen, W. J., Lee, W. C., Shau, W. Y., ... Chen, C. C. (2013). Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. Schizophrenia Bulletin, 39(3), 648-657. https://doi.org/10.1093/schbul/sbr202

Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. / Kuo, Chian Jue; Yang, Shu Yu; Liao, Ya Tang; Chen, Wei J.; Lee, Wen Chung; Shau, Wen Yi; Chang, Yao Tung; Tsai, Shang Ying; Chen, Chiao Chicy.

In: Schizophrenia Bulletin, Vol. 39, No. 3, 05.2013, p. 648-657.

Research output: Contribution to journalArticle

Kuo, CJ, Yang, SY, Liao, YT, Chen, WJ, Lee, WC, Shau, WY, Chang, YT, Tsai, SY & Chen, CC 2013, 'Second-generation antipsychotic medications and risk of pneumonia in schizophrenia', Schizophrenia Bulletin, vol. 39, no. 3, pp. 648-657. https://doi.org/10.1093/schbul/sbr202
Kuo, Chian Jue ; Yang, Shu Yu ; Liao, Ya Tang ; Chen, Wei J. ; Lee, Wen Chung ; Shau, Wen Yi ; Chang, Yao Tung ; Tsai, Shang Ying ; Chen, Chiao Chicy. / Second-generation antipsychotic medications and risk of pneumonia in schizophrenia. In: Schizophrenia Bulletin. 2013 ; Vol. 39, No. 3. pp. 648-657.
@article{9498e48dcbc74604acbf32599c35658e,
title = "Second-generation antipsychotic medications and risk of pneumonia in schizophrenia",
abstract = "This study assessed the association between second-generation antipsychotic medications and risk of pneumonia requiring hospitalization in patients with schizophrenia because the evidence is limited in the population. We enrolled a nationwide cohort of 33 024 inpatients with schizophrenia ranged in age from 18 to 65 years, who were derived from the National Health Insurance Research Database in Taiwan from 2000 to 2008. Cases (n = 1741) were defined as patients who developed pneumonia after their first psychiatric admissions. Risk set sampling was used to match each case with 4 controls by age, sex, and the year of the first admission based on nested case-control study. Antipsychotic exposure was categorized by type, duration, and daily dose, and the association between exposure and pneumonia was assessed using conditional logistic regression. We found that current use of clozapine (adjusted risk ratio = 3.18, 95{\%} CI: 2.62-3.86, P",
keywords = "clozapine, dose-dependent, pneumonia, second-generation antipsychotics",
author = "Kuo, {Chian Jue} and Yang, {Shu Yu} and Liao, {Ya Tang} and Chen, {Wei J.} and Lee, {Wen Chung} and Shau, {Wen Yi} and Chang, {Yao Tung} and Tsai, {Shang Ying} and Chen, {Chiao Chicy}",
year = "2013",
month = "5",
doi = "10.1093/schbul/sbr202",
language = "English",
volume = "39",
pages = "648--657",
journal = "Schizophrenia Bulletin",
issn = "0586-7614",
publisher = "Oxford University Press",
number = "3",

}

TY - JOUR

T1 - Second-generation antipsychotic medications and risk of pneumonia in schizophrenia

AU - Kuo, Chian Jue

AU - Yang, Shu Yu

AU - Liao, Ya Tang

AU - Chen, Wei J.

AU - Lee, Wen Chung

AU - Shau, Wen Yi

AU - Chang, Yao Tung

AU - Tsai, Shang Ying

AU - Chen, Chiao Chicy

PY - 2013/5

Y1 - 2013/5

N2 - This study assessed the association between second-generation antipsychotic medications and risk of pneumonia requiring hospitalization in patients with schizophrenia because the evidence is limited in the population. We enrolled a nationwide cohort of 33 024 inpatients with schizophrenia ranged in age from 18 to 65 years, who were derived from the National Health Insurance Research Database in Taiwan from 2000 to 2008. Cases (n = 1741) were defined as patients who developed pneumonia after their first psychiatric admissions. Risk set sampling was used to match each case with 4 controls by age, sex, and the year of the first admission based on nested case-control study. Antipsychotic exposure was categorized by type, duration, and daily dose, and the association between exposure and pneumonia was assessed using conditional logistic regression. We found that current use of clozapine (adjusted risk ratio = 3.18, 95% CI: 2.62-3.86, P

AB - This study assessed the association between second-generation antipsychotic medications and risk of pneumonia requiring hospitalization in patients with schizophrenia because the evidence is limited in the population. We enrolled a nationwide cohort of 33 024 inpatients with schizophrenia ranged in age from 18 to 65 years, who were derived from the National Health Insurance Research Database in Taiwan from 2000 to 2008. Cases (n = 1741) were defined as patients who developed pneumonia after their first psychiatric admissions. Risk set sampling was used to match each case with 4 controls by age, sex, and the year of the first admission based on nested case-control study. Antipsychotic exposure was categorized by type, duration, and daily dose, and the association between exposure and pneumonia was assessed using conditional logistic regression. We found that current use of clozapine (adjusted risk ratio = 3.18, 95% CI: 2.62-3.86, P

KW - clozapine

KW - dose-dependent

KW - pneumonia

KW - second-generation antipsychotics

UR - http://www.scopus.com/inward/record.url?scp=84876533595&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876533595&partnerID=8YFLogxK

U2 - 10.1093/schbul/sbr202

DO - 10.1093/schbul/sbr202

M3 - Article

C2 - 22282455

AN - SCOPUS:84876533595

VL - 39

SP - 648

EP - 657

JO - Schizophrenia Bulletin

JF - Schizophrenia Bulletin

SN - 0586-7614

IS - 3

ER -